Immune Checkpoint Inhibitors in Cancer Patients With Concurrent Active Tuberculosis: A Real-World Study in a High Tuberculosis Burden Region.

Liu X, Cai Y, Shao L, Liu H, An J

Open source

DOI
10.1093/ofid/ofag517
Published
2026 Sep
Container
Open forum infectious diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ofid/ofag517,
  title = {Immune Checkpoint Inhibitors in Cancer Patients With Concurrent Active Tuberculosis: A Real-World Study in a High Tuberculosis Burden Region.},
  author = {Liu X and Cai Y and Shao L and Liu H and An J},
  year = {2026},
  journal = {Open forum infectious diseases},
  doi = {10.1093/ofid/ofag517},
  url = {https://doi.org/10.1093/ofid/ofag517}
}

RIS

TY  - JOUR
TI  - Immune Checkpoint Inhibitors in Cancer Patients With Concurrent Active Tuberculosis: A Real-World Study in a High Tuberculosis Burden Region.
AU  - Liu X
AU  - Cai Y
AU  - Shao L
AU  - Liu H
AU  - An J
PY  - 2026
JO  - Open forum infectious diseases
DO  - 10.1093/ofid/ofag517
UR  - https://doi.org/10.1093/ofid/ofag517
ER  - 

APA

X, L., Y, C., L, S., H, L., & J, A. (2026). Immune Checkpoint Inhibitors in Cancer Patients With Concurrent Active Tuberculosis: A Real-World Study in a High Tuberculosis Burden Region.. Open forum infectious diseases. https://doi.org/10.1093/ofid/ofag517

Source records